kidney failure semaglutide Ozempic has benefits for disease as well as diabetes Semaglutide and Ozempic-like drugs may

Semaglutide significantly improved maximal walking distance in people with symptomatic peripheral arterial disease (PAD) and type 2 diabetes in a trial designed to evaluate the use of a GLP-1 agonist to manage PAD

Introduction The world of pharmaceuticals is buzzing with excitement over a new class of drugs - GLP-1 agonists - and their potential in the fight against obesity

So before we move quickly to external GLP-1 support, a more important question is: Are we activating endogenous pathways effectively

Read the full announcement here: #Semaglutide #GLP1 #CDMO #PharmaManufacturing #DrugDeviceCombination #Quality #Compliance #OneSourceCDMO #HealthCanada